Soru

Zorluk: ZorPharmacologic Interventions

A 24-year-old man comes to the emergency department due to sudden-onset severe dyspnea, palpitations, and lightheadedness that began while playing basketball. He reports no chest pain but feels as though he might pass out. His medical history is significant for a heart murmur identified during adolescence, though he was lost to follow-up. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 92/60 mmHg92/60\text{ mmHg}, pulse 132/min132\text{/min} and regular, and respirations 24/min24\text{/min}. Pulse oximetry is 91%91\% on room air. Physical examination reveals a harsh, crescendo-decrescendo systolic murmur at the left lower sternal border; the murmur's intensity increases when the patient transitions from a squatting to a standing position. Pulmonary auscultation reveals fine crackles at both lung bases. An electrocardiogram demonstrates sinus tachycardia with marked left ventricular hypertrophy and deep, narrow Q waves in the lateral leads. Which of the following is the most appropriate initial pharmacologic intervention?

  1. Intravenous metoprololCevap
  2. B
    Intravenous furosemide
  3. C
    Intravenous nitroglycerin
  4. D
    Intravenous dobutamine
  5. E
    Intravenous nitroprusside

Cevap

Intravenous metoprolol
The correct intervention is a beta-blocker (intravenous metoprolol). This patient is experiencing acute cardiovascular compromise secondary to hypertrophic obstructive cardiomyopathy (HOCM), characterized by a dynamic left ventricular outflow tract (LVOT) obstruction. The obstruction occurs when the anterior leaflet of the mitral valve is pulled toward the hypertrophied interventricular septum during systole (systolic anterior motion, or SAM). Exertion-induced tachycardia limits diastolic filling time, resulting in a smaller end-diastolic volume. A smaller ventricular cavity brings the mitral valve and septum closer together, acutely worsening the obstruction, dropping cardiac output, and causing backward failure (pulmonary crackles). Intravenous beta-blockers slow the heart rate (allowing more time for ventricular filling) and decrease myocardial contractility (reducing the flow velocity that triggers the Venturi effect on the mitral valve). Together, these actions increase ventricular volume, relieve the LVOT obstruction, and improve forward cardiac output.

Adım Adım Çözüm

1
Analyze the patient's presentation and physical exam findings.
The young patient has exertional presyncope, a murmur that increases with standing (decreased preload), and ECG findings of LVH. This is diagnostic of hypertrophic obstructive cardiomyopathy (HOCM).
Accurate diagnosis is required to understand the mechanism behind the patient's acute pulmonary edema (bibasilar crackles) and hypotension.
2
Determine the pathophysiological mechanism of the acute decompensation.
Tachycardia (from exertion) reduced diastolic filling time, lowering the left ventricular end-diastolic volume (LVEDV). This smaller cavity size brought the anterior leaflet of the mitral valve closer to the hypertrophied septum, worsening the dynamic left ventricular outflow tract (LVOT) obstruction via systolic anterior motion (SAM).
Identifying that the pulmonary edema is driven by severe diastolic dysfunction and dynamic obstruction, rather than systolic failure, dictates the treatment approach.
3
Select the appropriate pharmacologic intervention.
A negative chronotrope and negative inotrope (intravenous metoprolol) is required to slow the heart rate, increase LVEDV, and reduce the force of contraction, which will alleviate the LVOT obstruction and subsequently resolve the pulmonary edema.
Unlike standard systolic heart failure, treating HOCM with preload reducers (diuretics, nitrates) or inotropes is absolutely contraindicated and will worsen the shock state.

Anahtar Kavram

In patients with hypertrophic obstructive cardiomyopathy (HOCM) presenting with acute dynamic outflow obstruction and pulmonary edema, negative inotropes/chronotropes (e.g., beta-blockers) are indicated to increase ventricular volume and relieve the obstruction; preload-reducing and afterload-reducing agents are contraindicated.

Alternatif Yöntem

In patients who do not tolerate beta-blockers or when beta-blockers are contraindicated (e.g., severe reactive airway disease), non-dihydropyridine calcium channel blockers (such as intravenous verapamil or diltiazem) are the appropriate alternative negative inotropes/chronotropes to relieve the obstruction.
Tahmini Süre:1m 30s
Bu soruyu puanla